SPOP and gastric cancer: Moreover, ADAMTS9‐AS2 acted as a tumour suppressor that inhibited the progression of GC through regulating the SPOP, and these findings indicated that SPOP and ADAMTS9‐AS2 can be potential targets for GC treatment.